시장보고서
상품코드
1938718

수의용 CRO 및 CDMO 시장 보고서(2026년)

Veterinary CRO And CDMO Global Market Report 2026

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

수의약품 CRO 및 CDMO 시장 규모는 최근 현저한 성장을 달성하고 있습니다. 2025년 75억 3,000만 달러에서 2026년에는 82억 달러로, CAGR 8.9%로 확대가 전망되고 있습니다. 지난 수년간의 성장 요인으로는 △수의약품 기업의 자체 연구개발 능력의 한계 △반려동물 증가 △동물 질병 확산 △선진국의 CDMO 서비스 조기 도입 △혁신적 수의용 생물제제 및 의약품 수요 증가 등을 꼽을 수 있습니다.

수의약 CRO 및 CDMO 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 118억 1,000만 달러에 달하며, CAGR은 9.6%에 달할 전망입니다. 예측 기간 중의 성장 요인으로는 위탁 연구개발 및 제조 서비스 수요 증가, 동물용 의약품 개발 기술 발전, 수의용 생물제제 및 의약품의 성장, 세계 규제 준수 요건 확대, 동물용 정밀의료 도입 확대 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 동물용의약품 개발의 외주화 증가, 비임상 및 임상시험 서비스 확대, 규제 컨설팅 서비스 수요 증가, 고급 분석 및 제제 서비스 도입, 시판 후 조사 및 약물감시 분야에 대한 관심 증가 등을 꼽을 수 있습니다.

반려동물 양육률 증가는 향후 수년간 수의학 CRO 및 CDMO 시장의 성장을 촉진할 것으로 예측됩니다. 반려동물 사육은 개인 또는 가정이 가축화된 동물의 돌봄, 복지, 관리에 대한 책임을 의미하며, 장기적이고 법적, 윤리적 책임을 의미합니다. 반려동물 양육 증가는 반려동물이 가져다주는 정서적, 건강상 이점에 대한 인식이 높아졌기 때문입니다. 개인이 반려동물 돌봄을 통해 반려동물과의 교감, 스트레스 해소, 종합적인 건강 증진을 추구하는 추세가 강화되고 있기 때문입니다. 수의학 CRO 및 CDMO 시장은 이러한 추세를 지원하고 있으며, 반려동물 수가 증가함에 따라 반려동물의 건강과 안전을 지키기 위한 동물용 의약품, 백신, 치료제 개발 및 제조에 대한 수요가 증가하고 있습니다. 예를 들어 2025년 3월 미국 비영리단체 '미국 반려동물 제품 협회'가 발표한 자료에 따르면 반려동물을 한 마리 이상 기르는 미국 가정은 9,400만 가구로 2023년 8,200만 가구에서 증가했습니다. 이처럼 반려동물 사육의 보급 확대가 수의학 CRO 및 CDMO 시장의 성장에 기여하고 있습니다.

수의학 CRO 및 CDMO 시장에서 활동하는 주요 업체들은 의약품 개발 수명주기의 효율성과 컴플라이언스를 준수하는 상용화 프로세스를 가속화하기 위해 첨단 무균 제조, 동결건조, 특수 제형 대응 능력을 갖춘 통합된 멀티사이트 CDMO 네트워크 등 혁신적인 서비스 개발에 주력하고 있습니다. 서비스 개발에 주력하고 있습니다. 통합형 멀티사이트 CDMO 네트워크는 여러 제조 거점과 무균 다제 시스템, 동결건조, 유연포장 등의 전문 기술을 통합된 운영 및 품질관리 체계 하에 연계하여 의약품 개발부터 제조까지 엔드투엔드 서비스를 제공하는 협력 플랫폼입니다. 예를 들어 2025년 4월에는 의약품 개발, 제형, 분석 서비스, 무균 및 반고체 제제 제조, 포장 솔루션을 제공하는 영국 기반의 풀서비스 CDMO인 메리벨 제약 솔루션즈(Meribel Pharma Solutions)가 프랑스, 스페인, 스웨덴에 걸쳐 13개 시설로 구성된 네트워크를 통해을 개시했습니다. 이 네트워크는 초기 개발 단계부터 상업적 규모의 생산까지 제품을 지원하며, 경구용 고형제, 무방부제 다약제 투여 시스템, 인체 및 동물용 의약품을 위한 동결건조 기술 분야의 우수 센터를 제공합니다.

자주 묻는 질문

  • 수의약품 CRO 및 CDMO 시장 규모는 어떻게 변화하고 있나요?
  • 수의약품 CRO 및 CDMO 시장의 성장 요인은 무엇인가요?
  • 반려동물 양육률 증가는 수의약품 CRO 및 CDMO 시장에 어떤 영향을 미치나요?
  • 수의약품 CRO 및 CDMO 시장의 주요 업체들은 어떤 혁신적인 서비스를 개발하고 있나요?
  • 수의약품 CRO 및 CDMO 시장의 주요 동향은 무엇인가요?

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA 26.03.04

A veterinary CRO (Contract Research Organization) is a specialized service provider that conducts research and clinical trials to evaluate the safety and efficacy of veterinary drugs and healthcare products. On the other hand, a veterinary CDMO (Contract Development and Manufacturing Organization) is a specialized service provider that offers contract development and manufacturing services for veterinary drugs and healthcare products, assisting with formulation development, process optimization, and production.

The main services provided by veterinary CROs and CDMOs include discovery, development, manufacturing, packaging and labeling, and market approval and post-marketing. Drug discovery in the context of veterinary CDMO and CMO (Contract Manufacturing Organization) typically refers to early-stage research and development activities related to the identification and optimization of potential drug candidates on behalf of their clients. These services cover a broad spectrum of applications, including medicines, medical devices, pharmaceuticals, biologics, and others, for both companion animals and livestock animals.

Tariffs have affected the veterinary CRO and CDMO market by increasing costs for imported raw materials, APIs, and advanced laboratory equipment, particularly impacting development, manufacturing, and packaging segments in regions such as North America, Europe, and Asia-Pacific. Companion animal and livestock drug development services face the most significant impact. While tariffs have increased operational costs, they have also incentivized local manufacturing and process innovation, supporting regional service providers in reducing dependency on imports.

The veterinary cro and cdmo market research report is one of a series of new reports from The Business Research Company that provides veterinary cro and cdmo market statistics, including veterinary cro and cdmo industry global market size, regional shares, competitors with a veterinary cro and cdmo market share, detailed veterinary cro and cdmo market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary cro and cdmo industry. This veterinary cro and cdmo market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary cro and cdmo market size has grown strongly in recent years. It will grow from $7.53 billion in 2025 to $8.2 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to limited in-house r&d capabilities of veterinary companies, growing companion animal population, rising prevalence of animal diseases, early adoption of cdm/o services in developed regions, demand for innovative veterinary biologics and drugs.

The veterinary cro and cdmo market size is expected to see strong growth in the next few years. It will grow to $11.81 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing demand for contract research and manufacturing services, technological advancements in veterinary drug development, growth of veterinary biologics and pharmaceuticals, expansion of global regulatory compliance requirements, rising adoption of precision medicine for animals. Major trends in the forecast period include increasing outsourcing of veterinary drug development, expansion of preclinical and clinical trial services, growing demand for regulatory consulting services, adoption of advanced analytical and formulation services, rising focus on post-marketing surveillance and pharmacovigilance.

The rising level of pet ownership is expected to drive the growth of the veterinary CRO and CDMO market in the coming years. Pet ownership refers to the responsibility of an individual or household for the care, well-being, and management of a domesticated animal and represents a long-term legal and ethical commitment. The increase in pet ownership is driven by greater awareness of the emotional and health benefits associated with pets, as individuals increasingly seek companionship, stress reduction, and improved overall well-being through pet care. The veterinary CRO and CDMO market supports this trend, as a growing pet population increases demand for the development and manufacturing of veterinary drugs, vaccines, and therapies to safeguard pet health and safety. For example, in March 2025, the American Pet Products Association, a US-based non-profit organization, reported that 94 million US households owned at least one pet, compared with 82 million households in 2023. Therefore, the increasing prevalence of pet ownership is contributing to the growth of the veterinary CRO and CDMO market.

Leading players operating in the veterinary CRO and CDMO market are focusing on developing innovative service offerings, such as integrated multi-site CDMO networks with advanced sterile manufacturing, lyophilization, and specialized dosage capabilities, to streamline drug development lifecycles and accelerate compliant commercialization pathways. Integrated multi-site CDMO networks are coordinated platforms that bring together multiple manufacturing sites and specialized technologies-including sterile multidose systems, lyophilization, and flexible packaging-within unified operational and quality frameworks to deliver end-to-end pharmaceutical development and production services. For instance, in April 2025, Meribel Pharma Solutions, a UK-based full-service CDMO providing drug development, formulation, analytical services, sterile and semi-solid manufacturing, and packaging solutions, commenced operations with a network of 13 facilities across France, Spain, and Sweden. This network supports products from early-stage development through commercial-scale production and offers centers of excellence in oral solid dosage forms, preservative-free multidose systems, and lyophilization technologies for both human and veterinary health products.

In May 2023, Argenta, a Belgium-based contract research organization (CRO) and contract development and manufacturing organization (CDMO), acquired Midwest Veterinary Services Inc. for an undisclosed amount. This acquisition aims to enhance the service offerings of both companies, enabling them to provide a broader range of clinical research, product development, and manufacturing solutions. Midwest Veterinary Services Inc. is a US-based firm that specializes in veterinary CRO and CDMO services, concentrating on the development and testing of animal health solutions.

Major companies operating in the veterinary cro and cdmo market are Eurofins Scientific SE, Charles River Laboratories Inc., IDEXX Laboratories Inc., Elanco India Private Limited, Aenova Group, Taconic Bioscience Inc., knoell Germany GmbH, ClinVet International Pty Ltd., VetPharm Inc., Vetio Animal Health Company, Ridgeway Research Ltd., Drayton Animal Health Ltd., KLIFOVET GmbH, Cebiphar, Veterinary Research Management (VRM) Ltd., Vetspin Srl, STATKING Animal Health CRO, Arcoblu S.r.l., Syneos Health Inc., Pharmaceutical Product Development Inc., Inotiv Inc., Promega Corporation, Triveritas Ltd.

North America was the largest region in the veterinary CRO and CDMO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary cro and cdmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary cro and cdmo market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The veterinary CRO and CDMO market includes revenues earned by entities through contract research, development, and manufacturing services. This encompasses the income generated by these entities for conducting preclinical studies, clinical trials, pharmacokinetics, and pharmacodynamics testing, toxicology studies, formulation development, process optimization, and manufacturing of veterinary drugs and healthcare products. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary CRO And CDMO Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses veterinary cro and cdmo market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary cro and cdmo ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary cro and cdmo market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Service Type: Discovery; Development; Manufacturing; Packaging And Labeling; Market Approval And Post-marketing
  • 2) By Animal Type: Companion Animals; Livestock Animals
  • 3) By Application: Medicines; Medical Devices; Pharmaceuticals; Biologics; Other Applications
  • Subsegments:
  • 1) By Discovery: Target Identification; Target Validation; Lead Identification; Lead Optimization
  • 2) By Development: Preclinical Development; Clinical Development (Phase I, II, III); Regulatory Consulting
  • 3) By Manufacturing: API Manufacturing; Finished Dose Formulation; Analytical Services
  • 4) By Packaging And Labeling: Primary Packaging; Secondary Packaging; Label Design And Compliance
  • 5) By Market Approval And Post-marketing: Regulatory Submissions; Pharmacovigilance; Post-marketing Surveillance
  • Companies Mentioned: Eurofins Scientific SE; Charles River Laboratories Inc.; IDEXX Laboratories Inc.; Elanco India Private Limited; Aenova Group; Taconic Bioscience Inc.; knoell Germany GmbH; ClinVet International Pty Ltd.; VetPharm Inc.; Vetio Animal Health Company; Ridgeway Research Ltd.; Drayton Animal Health Ltd.; KLIFOVET GmbH; Cebiphar; Veterinary Research Management (VRM) Ltd.; Vetspin Srl; STATKING Animal Health CRO; Arcoblu S.r.l.; Syneos Health Inc.; Pharmaceutical Product Development Inc.; Inotiv Inc.; Promega Corporation; Triveritas Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Veterinary CRO And CDMO Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Veterinary CRO And CDMO Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Veterinary CRO And CDMO Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Veterinary CRO And CDMO Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Outsourcing Of Veterinary Drug Development
    • 4.2.2 Expansion Of Preclinical And Clinical Trial Services
    • 4.2.3 Growing Demand For Regulatory Consulting Services
    • 4.2.4 Adoption Of Advanced Analytical And Formulation Services
    • 4.2.5 Rising Focus On Post-Marketing Surveillance And Pharmacovigilance

5. Veterinary CRO And CDMO Market Analysis Of End Use Industries

  • 5.1 Veterinary Pharmaceutical Companies
  • 5.2 Biotechnology Firms
  • 5.3 Contract Research Organizations (Cros)
  • 5.4 Veterinary Hospitals And Clinics
  • 5.5 Regulatory Agencies

6. Veterinary CRO And CDMO Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Veterinary CRO And CDMO Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Veterinary CRO And CDMO PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Veterinary CRO And CDMO Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Veterinary CRO And CDMO Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Veterinary CRO And CDMO Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Veterinary CRO And CDMO Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Veterinary CRO And CDMO Market Segmentation

  • 9.1. Global Veterinary CRO And CDMO Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Discovery, Development, Manufacturing, Packaging And Labeling, Market Approval And Post-marketing
  • 9.2. Global Veterinary CRO And CDMO Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Companion Animals, Livestock Animals
  • 9.3. Global Veterinary CRO And CDMO Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications
  • 9.4. Global Veterinary CRO And CDMO Market, Sub-Segmentation Of Discovery, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Target Identification, Target Validation, Lead Identification, Lead Optimization
  • 9.5. Global Veterinary CRO And CDMO Market, Sub-Segmentation Of Development, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting
  • 9.6. Global Veterinary CRO And CDMO Market, Sub-Segmentation Of Manufacturing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • API Manufacturing, Finished Dose Formulation, Analytical Services
  • 9.7. Global Veterinary CRO And CDMO Market, Sub-Segmentation Of Packaging And Labeling, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Primary Packaging, Secondary Packaging, Label Design And Compliance
  • 9.8. Global Veterinary CRO And CDMO Market, Sub-Segmentation Of Market Approval And Post-marketing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Regulatory Submissions, Pharmacovigilance, Post-marketing Surveillance

10. Veterinary CRO And CDMO Market Regional And Country Analysis

  • 10.1. Global Veterinary CRO And CDMO Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Veterinary CRO And CDMO Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Veterinary CRO And CDMO Market

  • 11.1. Asia-Pacific Veterinary CRO And CDMO Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Veterinary CRO And CDMO Market

  • 12.1. China Veterinary CRO And CDMO Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Veterinary CRO And CDMO Market

  • 13.1. India Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Veterinary CRO And CDMO Market

  • 14.1. Japan Veterinary CRO And CDMO Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Veterinary CRO And CDMO Market

  • 15.1. Australia Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Veterinary CRO And CDMO Market

  • 16.1. Indonesia Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Veterinary CRO And CDMO Market

  • 17.1. South Korea Veterinary CRO And CDMO Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Veterinary CRO And CDMO Market

  • 18.1. Taiwan Veterinary CRO And CDMO Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Veterinary CRO And CDMO Market

  • 19.1. South East Asia Veterinary CRO And CDMO Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Veterinary CRO And CDMO Market

  • 20.1. Western Europe Veterinary CRO And CDMO Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Veterinary CRO And CDMO Market

  • 21.1. UK Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Veterinary CRO And CDMO Market

  • 22.1. Germany Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Veterinary CRO And CDMO Market

  • 23.1. France Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Veterinary CRO And CDMO Market

  • 24.1. Italy Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Veterinary CRO And CDMO Market

  • 25.1. Spain Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Veterinary CRO And CDMO Market

  • 26.1. Eastern Europe Veterinary CRO And CDMO Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Veterinary CRO And CDMO Market

  • 27.1. Russia Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Veterinary CRO And CDMO Market

  • 28.1. North America Veterinary CRO And CDMO Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Veterinary CRO And CDMO Market

  • 29.1. USA Veterinary CRO And CDMO Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Veterinary CRO And CDMO Market

  • 30.1. Canada Veterinary CRO And CDMO Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Veterinary CRO And CDMO Market

  • 31.1. South America Veterinary CRO And CDMO Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Veterinary CRO And CDMO Market

  • 32.1. Brazil Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Veterinary CRO And CDMO Market

  • 33.1. Middle East Veterinary CRO And CDMO Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Veterinary CRO And CDMO Market

  • 34.1. Africa Veterinary CRO And CDMO Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Veterinary CRO And CDMO Market, Segmentation By Service Type, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Veterinary CRO And CDMO Market Regulatory and Investment Landscape

36. Veterinary CRO And CDMO Market Competitive Landscape And Company Profiles

  • 36.1. Veterinary CRO And CDMO Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Veterinary CRO And CDMO Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Veterinary CRO And CDMO Market Company Profiles
    • 36.3.1. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Charles River Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. IDEXX Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Elanco India Private Limited Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Aenova Group Overview, Products and Services, Strategy and Financial Analysis

37. Veterinary CRO And CDMO Market Other Major And Innovative Companies

  • Taconic Bioscience Inc., knoell Germany GmbH, ClinVet International Pty Ltd., VetPharm Inc., Vetio Animal Health Company, Ridgeway Research Ltd., Drayton Animal Health Ltd., KLIFOVET GmbH, Cebiphar, Veterinary Research Management (VRM) Ltd., Vetspin Srl, STATKING Animal Health CRO, Arcoblu S.r.l., Syneos Health Inc., Pharmaceutical Product Development Inc.

38. Global Veterinary CRO And CDMO Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Veterinary CRO And CDMO Market

40. Veterinary CRO And CDMO Market High Potential Countries, Segments and Strategies

  • 40.1 Veterinary CRO And CDMO Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Veterinary CRO And CDMO Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Veterinary CRO And CDMO Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제